KPF
AGN

K2 Principal Fund’s Allergan plc AGN Stock Holding History

K2 Principal Fund’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$2.1M – 389
2016
Q4 		$2.1M Sell
10,000
-15,000
-60% -$3.11M 0.2% 112
2016
Q3 		$5.76M Buy
25,000
+21,000
+525% +$5.13M 0.65% 38
2016
Q2 		$924K Buy
+4,000
New +$922K 0.12% 139
2015
Q2 		– Sell
-12,500
Closed -$3.72M – 217
2015
Q1 		$3.72M Buy
+12,500
New +$3.56M 0.78% 40

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

K2 Principal Fund's AGN Position: Q2 2020 in Review

K2 Principal Fund sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 46,377 shares — an estimated $8.21M sold.

K2 Principal Fund first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $9.22M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • K2 Principal Fund reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • K2 Principal Fund sold 46,377 Allergan plc shares in Q2 2020, an estimated $8.21M.
  • K2 Principal Fund first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • K2 Principal Fund's Allergan plc position peaked at $9.22M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on K2 Principal Fund's 13F filing for Q2 2020, filed 13 Aug 2020.